Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Mercado Continuo Espanol  >  Grifols SA       ES0171996012

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (€)
Sales 2016 4 126 M
EBIT 2016 1 050 M
Net income 2016 580 M
Debt 2016 3 372 M
Yield 2016 1,88%
Sales 2017 4 267 M
EBIT 2017 1 115 M
Net income 2017 670 M
Debt 2017 3 063 M
Yield 2017 2,10%
P/E ratio 2016 21,17
P/E ratio 2017 18,40
EV / Sales 2016 3,59x
EV / Sales 2017 3,40x
Capitalization 11 428 M
More Financials
Company
Grifols SA is a vertically integrated global producer of plasma derivatives.Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers.The company operates through four segments: Bioessence,... 
Sector
Pharmaceuticals
Calendar
05/26 | 06:00amShareholder meeting
More about the company
Surperformance© ratings of Grifols SA
Trading Rating : Investor Rating :
More Ratings
Latest news on GRIFOLS SA
09:45a GRIFOLS' : revenues increase by +5.6% to Euros 959 million, driven by growth of ..
02:55a GRIFOLS' : revenues increase by +5.6% to Euros 959 million, driven by growth of ..
04/22 GRIFOLS : dedicates green building
04/18 GRIFOLS : The Catalan Down's Syndrome Foundation and Grifols are working togethe..
04/18 GRIFOLS : The Catalan Down's Syndrome Foundation and Grifols are working togethe..
03/23 GRIFOLS : Therapeutics Assigned Patent
03/18 IBERDROLA : Women Make Gains On Spanish Boards
03/14 GRIFOLS : Aradigm Announces Fourth Quarter 2015 and Full Year Financial Results
More news
Sector news : Biopharmaceuticals
02:27pDJSANOFI : Will Try to Oust Medivation Board Unless Deal Talks Start -- Update
02:02pDJMARKET SNAPSHOT : U.S. Stocks Turn Negative As Oil Futures Pare Gains
01:38pDJREGENERON PHARMACEUTICALS : Raises Sales Expectations for Eylea -- Update
More sector news : Biopharmaceuticals
News from SeekingAlpha
01/04 Midday Gainers / Losers
2015 Tracking John Paulson's Paulson & Company Portfolio - Q3 2015 Update
2015 TiGenix Achieves First Ever Success In Allogeneic Stem Cell Phase 3 Trial
2015 Tracking John Paulson's Paulson & Company Portfolio - Q2 2015 Update
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Comments 
Advertisement
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | ES0171996012 | 4-Traders
Full-screen chart
Technical analysis trends GRIFOLS SA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions